Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ray Borrow

Showing results (311-320 of 403) with videos related to

Pageof 41
Sort By:
Vaccine|June 13, 2022
Immunogenicity of a single 4CMenB vaccine booster in adolescents 11 years after childhood immunisationChristine S Rollier, Christina Dold, Luke Blackwell, et al.
The Journal of Infection|April 30, 2017
Meningococcal disease in the Middle East and Africa: Findings and updates from the Global Meningococcal InitiativeRay Borrow, Dominique A Caugant, Mehmet Ceyhan, et al.
Journal of Clinical Microbiology|September 2, 2016
Alternative Molecular Methods for Improved Detection of Meningococcal Carriage and Measurement of Bacterial DensityOlivier Manigart, Jacinta Okeakpu, Aderonke Odutola, et al.
Emerging Infectious Diseases|June 21, 2021
Seroprevalence of SARS-CoV-2 among Blood Donors and Changes after Introduction of Public Health and Social Measures, London, UKGayatri Amirthalingam, Heather Whitaker, Tim Brooks, et al.
BMJ (Clinical Research Ed.)|April 3, 2015
Immunogenicity of reduced dose priming schedules of serogroup C meningococcal conjugate vaccine followed by booster at 12 months in infants: open label randomised controlled trialDavid Pace, Ameneh Khatami, Jennifer McKenna, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|December 6, 2016
An international invasive meningococcal disease outbreak due to a novel and rapidly expanding serogroup W strain, Scotland and Sweden, July to August 2015Jay Lucidarme, Kevin J Scott, Roisin Ure, et al.
The Lancet. Infectious Diseases|April 4, 2017
Meningococcal serogroup B strain coverage of the multicomponent 4CMenB vaccine with corresponding regional distribution and clinical characteristics in England, Wales, and Northern Ireland, 2007-08 and 2014-15: a qualitative and quantitative assessmentSydel R Parikh, Lynne Newbold, Stephanie Slater, et al.
Infection and Immunity|April 2, 2014
Phase variation mediates reductions in expression of surface proteins during persistent meningococcal carriageMohamed Alamro, Fadil A Bidmos, Hannah Chan, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 31, 2006
The rise and fall of epidemic Neisseria meningitidis serogroup W135 meningitis in Burkina Faso, 2002-2005Yves Traoré, Berthe-Marie Njanpop-Lafourcade, Kokou-Louis-Sewonou Adjogble, et al.
BMJ Open|July 12, 2018
B Part of It protocol: a cluster randomised controlled trial to assess the impact of 4CMenB vaccine on pharyngeal carriage of <i>Neisseria meningitidis</i> in adolescentsHelen S Marshall, Mark McMillan, Ann Koehler, et al.
Pageof 41

Showing results (311-320 of 403) with videos related to

Sort By:
Pageof 41
Vaccine|June 13, 2022
Immunogenicity of a single 4CMenB vaccine booster in adolescents 11 years after childhood immunisationChristine S Rollier, Christina Dold, Luke Blackwell, et al.
The Journal of Infection|April 30, 2017
Meningococcal disease in the Middle East and Africa: Findings and updates from the Global Meningococcal InitiativeRay Borrow, Dominique A Caugant, Mehmet Ceyhan, et al.
Journal of Clinical Microbiology|September 2, 2016
Alternative Molecular Methods for Improved Detection of Meningococcal Carriage and Measurement of Bacterial DensityOlivier Manigart, Jacinta Okeakpu, Aderonke Odutola, et al.
Emerging Infectious Diseases|June 21, 2021
Seroprevalence of SARS-CoV-2 among Blood Donors and Changes after Introduction of Public Health and Social Measures, London, UKGayatri Amirthalingam, Heather Whitaker, Tim Brooks, et al.
BMJ (Clinical Research Ed.)|April 3, 2015
Immunogenicity of reduced dose priming schedules of serogroup C meningococcal conjugate vaccine followed by booster at 12 months in infants: open label randomised controlled trialDavid Pace, Ameneh Khatami, Jennifer McKenna, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|December 6, 2016
An international invasive meningococcal disease outbreak due to a novel and rapidly expanding serogroup W strain, Scotland and Sweden, July to August 2015Jay Lucidarme, Kevin J Scott, Roisin Ure, et al.
The Lancet. Infectious Diseases|April 4, 2017
Meningococcal serogroup B strain coverage of the multicomponent 4CMenB vaccine with corresponding regional distribution and clinical characteristics in England, Wales, and Northern Ireland, 2007-08 and 2014-15: a qualitative and quantitative assessmentSydel R Parikh, Lynne Newbold, Stephanie Slater, et al.
Infection and Immunity|April 2, 2014
Phase variation mediates reductions in expression of surface proteins during persistent meningococcal carriageMohamed Alamro, Fadil A Bidmos, Hannah Chan, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 31, 2006
The rise and fall of epidemic Neisseria meningitidis serogroup W135 meningitis in Burkina Faso, 2002-2005Yves Traoré, Berthe-Marie Njanpop-Lafourcade, Kokou-Louis-Sewonou Adjogble, et al.
BMJ Open|July 12, 2018
B Part of It protocol: a cluster randomised controlled trial to assess the impact of 4CMenB vaccine on pharyngeal carriage of <i>Neisseria meningitidis</i> in adolescentsHelen S Marshall, Mark McMillan, Ann Koehler, et al.
Pageof 41